ZA886909B - Prostaglandins of the f series - Google Patents

Prostaglandins of the f series

Info

Publication number
ZA886909B
ZA886909B ZA886909A ZA886909A ZA886909B ZA 886909 B ZA886909 B ZA 886909B ZA 886909 A ZA886909 A ZA 886909A ZA 886909 A ZA886909 A ZA 886909A ZA 886909 B ZA886909 B ZA 886909B
Authority
ZA
South Africa
Prior art keywords
pgfs
blood pressure
prostaglandins
series
vassopressors
Prior art date
Application number
ZA886909A
Other languages
English (en)
Inventor
Ryuzo Ueno
Ueno Ryuzo
Ryuji Ueno
Ueno Ryuji
Tomio Oda
Oda Tomio
Original Assignee
Ueno Seiyaku Oyo Kenkyujo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo Kk filed Critical Ueno Seiyaku Oyo Kenkyujo Kk
Publication of ZA886909B publication Critical patent/ZA886909B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
ZA886909A 1987-04-30 1988-09-16 Prostaglandins of the f series ZA886909B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10752987 1987-04-30
JP23589087 1987-09-18
EP88303931A EP0289349B1 (en) 1987-04-30 1988-04-29 Prostaglandins of the f series

Publications (1)

Publication Number Publication Date
ZA886909B true ZA886909B (en) 1989-05-30

Family

ID=26447552

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA886909A ZA886909B (en) 1987-04-30 1988-09-16 Prostaglandins of the f series

Country Status (11)

Country Link
US (1) US5106869A (cs)
EP (1) EP0289349B1 (cs)
JP (1) JPH0667900B2 (cs)
KR (1) KR930006202B1 (cs)
AT (1) ATE72235T1 (cs)
CA (1) CA1324129C (cs)
DE (2) DE10399038I2 (cs)
ES (1) ES2032016T3 (cs)
GR (1) GR3003749T3 (cs)
NL (1) NL300135I2 (cs)
ZA (1) ZA886909B (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
JP2721414B2 (ja) * 1988-09-06 1998-03-04 フアーマシア・アンド・アツプジヨン・アー・ベー 縁内障または眼圧亢進の治療のためのプロスタグランジン誘導体
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE122563T1 (de) * 1989-07-27 1995-06-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
DE69018903T2 (de) * 1989-08-09 1995-08-24 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme.
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
CA2039420C (en) * 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ES2093774T3 (es) * 1991-03-14 1997-01-01 R Tech Ueno Ltd Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
US5221690A (en) * 1991-10-02 1993-06-22 R-Tech Ueno Ltd. Increasing the choroidal blood flow
ES2105333T3 (es) * 1992-10-13 1997-10-16 Alcon Lab Inc Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.
US6294563B1 (en) 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
HU223345B1 (hu) 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
AU7680096A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
US6770675B2 (en) 1997-03-17 2004-08-03 Novartis Ag Compositions and methods for reducing ocular hypertension
AU731032B2 (en) * 1997-09-09 2001-03-22 Duke University Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists
TWI225398B (en) * 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
AU2603301A (en) 1999-12-22 2001-07-03 Alcon Universal Limited 6-keto prostaglandin F1alpha and analogs for treating dry eye
WO2004019951A1 (ja) * 2002-08-29 2004-03-11 Santen Pharmaceutical Co., Ltd. Rhoキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
EP2404606A1 (en) 2003-08-21 2012-01-11 Sucampo AG Ophthalmic compositions comprising a prostaglandin and a viscosity agent
KR101091461B1 (ko) 2003-11-07 2011-12-07 센주 세이야꾸 가부시키가이샤 프로스타글란딘 함유 의약 조성물
KR20070090218A (ko) * 2004-12-29 2007-09-05 가부시키가이샤 아루떼꾸 우에노 두피 및 모발 치료용 조성물 및 치료 방법
NZ570191A (en) * 2006-01-24 2010-09-30 R Tech Ueno Ltd Soft-gelatin capsule formulation comprising a keto-prostaglandin compound
AU2007225798B2 (en) 2006-03-13 2012-09-06 R-Tech Ueno, Ltd. Aqueous composition
EP2694077A4 (en) 2011-04-07 2015-01-21 Sucampo Ag METHOD FOR TREATING ASTHENOPY
AU2012293157A1 (en) 2011-08-05 2014-03-13 Sucampo Ag Method for treating schizophrenia
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
JP6162646B2 (ja) * 2014-05-27 2017-07-12 信越化学工業株式会社 ３，５−ジメチルドデカン酸の製造方法
US20170020890A1 (en) 2015-06-19 2017-01-26 Sucampo Ag Pharmaceutical composition comprising fatty acid derivative

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505386A (en) * 1965-12-29 1970-04-07 Upjohn Co Compounds related to prostaglandins
US3984455A (en) * 1973-07-16 1976-10-05 The Upjohn Company Prostaglandin E1 analogs
GB1476661A (en) * 1974-05-13 1977-06-16 American Cyanamid Co Prostaglandins
IL51189A (en) * 1976-02-04 1985-08-30 Upjohn Co Prostaglandin analogs
JPS60208917A (ja) * 1984-02-29 1985-10-21 ジ・アツプジヨン・カンパニー Ａｒｄｓおよび多器官不全治療、予防におけるプロスタグランジンの使用
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
FR2613722B1 (fr) * 1987-04-07 1990-11-23 Bp Chimie Sa Procede de fabrication de granules d'homopolymere ou de copolymere de propylene

Also Published As

Publication number Publication date
NL300135I2 (nl) 2004-05-03
DE10399038I2 (de) 2004-09-23
NL300135I1 (nl) 2003-12-01
DE3868127D1 (de) 1992-03-12
ATE72235T1 (de) 1992-02-15
DE10399038I1 (de) 2004-05-06
ES2032016T3 (es) 1993-01-01
JPH0667900B2 (ja) 1994-08-31
US5106869A (en) 1992-04-21
KR930006202B1 (ko) 1993-07-08
EP0289349B1 (en) 1992-01-29
CA1324129C (en) 1993-11-09
KR880012540A (ko) 1988-11-28
EP0289349A1 (en) 1988-11-02
JPH01151552A (ja) 1989-06-14
GR3003749T3 (cs) 1993-03-16

Similar Documents

Publication Publication Date Title
ZA886909B (en) Prostaglandins of the f series
DE3883551D1 (de) Druckausbalancierte Dichtung mit "S" Querschnitt.
AU567257B2 (en) Sucralfat-suspension
CA1251462C (cs)
NO860758L (cs)
FI853255A7 (fi) Menetelmä 6-kloori-N-metyyli-2,3,4,5 -tetrahydro-1H-3-bentsatsepiinin valmistamiseksi.
IT8422916A0 (it) Procedimento per la produzione dicorpi carboniosi.
ATE88349T1 (de) Hyperimmunizierte milch gegen bluthochdruck.
IT8820935A0 (it) Procedimento per la preparazione di 1,2,5,6,9,10 esabromociclododecano.
EP0340391A3 (en) 1,4-disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides
PH24094A (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
EP0183538A3 (en) 2,2' -isopropylidine bis (tetrahydrofuran) and method of preparation
IE810767L (en) Prepartion of 2, 2, 6, 6-tetramethylpiperidone-4.
CA2001782A1 (en) 3-(3-propan-2-ylphenyl) butanal and 3-(3-propen-2-ylphenyl) butanal and their use as odorants
DE68925355D1 (de) 24r-scymnol, herstellung und verwendung
FI851969A7 (fi) Korkean verenpaineen hoitoon soveltuvia tetrahydronaftalenoleja.
IT8422915A0 (it) Procedimento per la produzione dicorpi carboniosi.
IT8821003A0 (it) Procedimento per la preparazione del "alfa /4(1,1 dimetiletil)fenil/ 4 (idrossidifenilmetil) 1piperidinbutanolo".
SU1233456A1 (ru) Способ получения замещенных n-[(1,3,5-триазин-2-ил)аминокарбонил]бензолсульфонамидов
SU1216944A1 (ru) Способ получения 2,6-ди-трет-бутилфенола
FI883499A7 (fi) Menetelmä aryyli- tai heteroaryylimetyylisubstituoitujen 2.2'-bi-1H-imidatsolien valmistamiseksi
IT8520633A0 (it) Procedimento per la preparazione della 1-(4,6-bis-allilammino-s-triazinil)-4-(p,p'-difluorobenzidril)piperazi na.
SU925072A1 (ru) Способ получения 2,5-диметокси-2-диметоксиметил-2,5-дигидрофурана
EP0108451A3 (en) Novel prostaglandin analogues
NO890473L (no) Analogifremgangsmaate for fremstilling av 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner.